Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| INCYTE CORP | 227,594 | reported | 30 Jun 2011 | tx 14+3,887−24,467 |
| GENOMIC HEALTH INC | 194,184 | reported | 17 Aug 2009 | tx 18+3,926 |
| INTRABIOTICS PHARMACEUTICALS INC /DE | 126,709 | reported | 30 Jun 2011 | tx 7+829−68,873 |
| VIROPHARMA INC | 105,432 | reported | 13 May 2009 | tx 26+2,932−58,088 |
| BIOCRYST PHARMACEUTICALS INC | 71,997 | reported | 01 Jun 2009 | tx 6−37,719 |
| TAPESTRY PHARMACEUTICALS, INC | 41,120 | reported | 03 Apr 2008 | tx 1−521 |
| IDERA PHARMACEUTICALS, INC. | 40,077 | reported | 29 Jul 2008 | tx 26−46,004 |
| NEUROGEN CORP | 9,904 | reported | 11 Apr 2008 | tx 3+19,808−17,987 |
| AUXILIUM PHARMACEUTICALS INC | 6,992 | reported | 30 Mar 2011 | tx 1+309 |
| ALLOS THERAPEUTICS INC | 2,258 | reported | 23 Jan 2009 | tx 12+1,160−75,118 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Jan 2012 | SALE | VAXGEN INC | 59,340 | 0.22 USD | |
| 19 Jan 2012 | SALE | VAXGEN INC | 20,000 | 0.20 USD | |
| 18 Jan 2012 | SALE | VAXGEN INC | 118,800 | 0.21 USD | |
| 30 Dec 2011 | EXERCISE | SEATTLE GENETICS INC /WA | 68,006 | 6.25 USD | |
| 30 Dec 2011 | EXERCISE | SEATTLE GENETICS INC /WA | 68,006 | 0.00 USD | deriv |
| 30 Jun 2011 | OTHER | INTRABIOTICS PHARMACEUTICALS INC /DE | 9,301 | 0.00 USD | |
| 30 Jun 2011 | OTHER | SEATTLE GENETICS INC /WA | 10,766 | 0.00 USD | |
| 30 Jun 2011 | OTHER | INCYTE CORP | 11,664 | 0.00 USD | |
| 24 Apr 2011 | PURCHASE | HERON THERAPEUTICS, INC. /DE/ | 600 | 0.00 USD | deriv |
| 24 Apr 2011 | PURCHASE | HERON THERAPEUTICS, INC. /DE/ | 300 | 300.00 USD | deriv |
| 30 Mar 2011 | PURCHASE | AUXILIUM PHARMACEUTICALS INC | 309 | 21.98 USD | first after silence |
| 09 Aug 2010 | SALE | INCYTE CORP | 3,938 | 14.09 USD | |
| 10 Aug 2010 | SALE | INCYTE CORP | 1,856 | 14.00 USD | |
| 10 Aug 2010 | SALE | INCYTE CORP | 956 | 14.00 USD | |
| 09 Aug 2010 | SALE | INCYTE CORP | 6,053 | 14.08 USD | |
| 17 Aug 2009 | PURCHASE | GENOMIC HEALTH INC | 1 | 19.60 USD | |
| 13 Aug 2009 | PURCHASE | GENOMIC HEALTH INC | 33 | 19.99 USD | |
| 01 Jun 2009 | SALE | BIOCRYST PHARMACEUTICALS INC | 8,067 | 3.86 USD | |
| 01 Jun 2009 | SALE | BIOCRYST PHARMACEUTICALS INC | 3,124 | 3.89 USD | |
| 28 May 2009 | SALE | BIOCRYST PHARMACEUTICALS INC | 6,174 | 4.45 USD | |
| 28 May 2009 | SALE | BIOCRYST PHARMACEUTICALS INC | 11,128 | 4.50 USD | |
| 29 May 2009 | SALE | BIOCRYST PHARMACEUTICALS INC | 1,500 | 4.30 USD | |
| 29 May 2009 | SALE | BIOCRYST PHARMACEUTICALS INC | 7,726 | 4.12 USD | |
| 20 May 2009 | PURCHASE | SEATTLE GENETICS INC /WA | 3,710 | 9.72 USD | |
| 13 May 2009 | PURCHASE | VIROPHARMA INC | 45 | 5.45 USD |
1 purchase reported after at least 12 months of silence — most recent on 30 Mar 2011.